Keyword: Novartis


EMA Reviewing Approval of Novartis’ Adakveo

31.01.2023 -

The European Medicines Agency (EMA) said its Committee for Medicinal Products for Human Use (CHMP) has begun reviewing its marketing authorization for Novartis’ Adakveo...


Novartis to Pay $245 Million in ’Pay for Delay’ Settlement

05.01.2023 -

Novartis has agreed to pay a total of $245 million to settle lawsuits filed by direct purchasers, indirect purchasers and retailers accusing it of colluding with Par...


Jobs to Go at Novartis US Headquarters

22.12.2022 -

As part of plans, announced in dribbles, to carve 8,000 jobs out of its global workforce to save $1 billion, Swiss drugs giant Novartis is eliminating 285 staff positions...


BioNTech Buys Novartis Singapore Plant for Asia HQ

15.11.2022 -

German Covid-19 vaccine specialist BioNTech has acquired a production facility in Singapore from Swiss drugmaker Novartis that will serve as a manufacturing base in...


Sandoz Invests in Extra European Antibiotic Capacity

09.11.2022 -

Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to spend an additional €50 million on raising European manufacturing capacity for finished...

Plant Construction & Process Technology

AI Maturity Model for GxP Application

18.10.2022 -

Artificial intelligence (AI) has become one of the supporting pillars for digitalization in many areas of the business world. The pharmaceutical industry and its GxP...


Novartis to Shutter a Sandoz US Plant

09.09.2022 -

In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US...


Novartis Sued over its own Drug

06.09.2022 -

Swiss drugmaker Novartis, already embroiled in a number of lawsuits against generics producers seeking to create copies of its blockbuster cardiac insufficiency treatment...